NCT03966443 (FLUCIPET) is a clinical trial in Myeloma, Multiple, sponsored by Oslo University Hospital.

Who is sponsoring NCT03966443?

NCT03966443 is sponsored by Oslo University Hospital.

What condition does NCT03966443 study?

NCT03966443 studies Myeloma, Multiple, PET-CT.

Is NCT03966443 still recruiting?

NCT03966443 is currently recruiting now. Last updated 30 May 2019.

Last reviewed 2019-05-30 · How we verify

NCT03966443: FLUCIPET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluciclovine PET/CT in Multiple Myeloma Patients

Recruiting now Last updated 30 May 2019

What this trial tests

trial in Myeloma, Multiple in 10 participants. Currently enrolling.

Timeline

1 March 2019

Primary endpoint
31 January 2020

31 January 2029

Quick facts

Lead sponsor	Oslo University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	10
Start date	1 March 2019
Primary completion	31 January 2020
Estimated completion	31 January 2029
Sites	1 location across Norway

Conditions studied

Myeloma, Multiple — all drugs for Myeloma, Multiple →
PET-CT — all drugs for PET-CT →

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Myeloma, Multiple or PET-CT. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Comparison of [<sup>18</sup>F]fluciclovine and [<sup>18</sup>F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.
Stokke C, Nørgaard JN, Feiring Phillips H, Sherwani A, et al · · 2022 · cited 12× · PMID 35501622 · DOI 10.1007/s11307-022-01734-0
Current and Future PET Imaging for Multiple Myeloma.
Ishibashi M, Takahashi M, Yamaya T, Imai Y. · · 2023 · cited 4× · PMID 37629558 · DOI 10.3390/life13081701
Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020
· 2020

Verify or expand the search:

Other recruiting trials for Myeloma, Multiple

Currently open trials in the same condition.

NCT07205523 — High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03966443 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 30 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing